Silencing hepatic MCJ attenuates non-alcoholic fatty liver disease (NAFLD) by increasing mitochondrial fatty acid oxidation
2020 · Nature Communications · 143 citations
https://doi.org/10.1038/s41467-020-16991-2
T
Teresa C. Delgado
Ikerbasque(ES)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
138
Papers
3.1K
Citations
35
h-index
61
i10-index
Teresa C. Delgado is an academic researcher from Ikerbasque. The author has contributed to research in topics: Liver Disease Diagnosis and Treatment & Cancer, Hypoxia, and Metabolism & Diet, Metabolism, and Disease. The author has an h-index of 35, co-authored 118 publications.
ORCID: 0000-0001-9204-581XPapers by this author
worksThe mitochondrial negative regulator MCJ is a therapeutic target for acetaminophen-induced liver injury
2017 · Nature Communications · 107 citations
https://doi.org/10.1038/s41467-017-01970-x
Inhibition of carnitine palmitoyltransferase 1A in hepatic stellate cells protects against fibrosis
2022 · Journal of Hepatology · 100 citations
https://doi.org/10.1016/j.jhep.2022.02.003
miR-873-5p targets mitochondrial GNMT-Complex II interface contributing to non-alcoholic fatty liver disease
2019 · Molecular Metabolism · 47 citations
https://doi.org/10.1016/j.molmet.2019.08.008
Methionine adenosyltransferase 1a antisense oligonucleotides activate the liver-brown adipose tissue axis preventing obesity and associated hepatosteatosis
2022 · Nature Communications · 47 citations
https://doi.org/10.1038/s41467-022-28749-z
MiR-873-5p acts as an epigenetic regulator in early stages of liver fibrosis and cirrhosis
2018 · Cell Death and Disease · 46 citations
https://doi.org/10.1038/s41419-018-1014-y
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat